A 16-week trial involving children with type 1 diabetes (T1D) found glucose level was in the target range for a greater percentage of time in individuals who used a closed-loop system compared with ...
During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback